Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase

Lactate dehydrogenase (LDH) in serum has recently been introduced into the American Joint Committee on Cancer (AJCC) staging system for cutaneous melanoma because of its prognostic value. We hypothesised LDH to be of value in discriminating melanoma patients entering AJCC stage IV from patients stay...

Descripción completa

Detalles Bibliográficos
Autores principales: Deichmann, M, Kahle, B, Moser, K, Wacker, J, Wüst, K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364774/
https://www.ncbi.nlm.nih.gov/pubmed/15280926
http://dx.doi.org/10.1038/sj.bjc.6602043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364774/
https://www.ncbi.nlm.nih.gov/pubmed/15280926
http://dx.doi.org/10.1038/sj.bjc.6602043

Ejemplares similares